Bergstrom Nutrition announced that Adrian Polliack, PhD, will be the company’s new president and CEO.
Bergstrom Nutrition (Vancouver, WA) announced that Adrian Polliack, PhD, will be the company’s new president and CEO. For the past four years, Polliack served as CEO of Diatmomix, a specialty chemical developer and manufacturer of air purifying technology. He has worked with Bergstrom previously while running Bridge Biomedical Consulting, in 2015. Polliack worked with Bergstrom’s leadership team to uncover new uses for methylsulfonylmethane (MSM).
“My previous work with Bergstrom Nutrition offered me a glimpse into the many possibilities for MSM. Today I’m thrilled at the prospect of embarking upon yet another exploration of OptiMSM’s bright future,” said Polliack, in a press release. “Bergstrom Nutrition has demonstrated an unwavering commitment to quality and expanding its usage, in part due to the vast amount of lab and clinical research it undertakes. In 2015, I consulted with Bergstrom on implementing a stage-gate process to begin vetting new product development and claims opportunities. It’s my hope to put that framework to better use so we can offer our customers studies with more defined outcomes and marketable claims.”